Positive and negative regulation of prostaglandin E2 biosynthesis in human colorectal carcinoma cells by cancer chemopreventive agents

Biochemical Pharmacology

Volumn 66, Issue 1, 2003, Pages 51-61

  Sherratt, Philip J ^a,b   McLellan, Lesley I ^a   Hayes, John D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Antioxidant responsive element; Cyclooxygenase; Indoles; Piroxicam; Prostaglandin E2; Tert Butylhydroquinone

Indexed keywords

ANTINEOPLASTIC AGENT; BETA NAPHTHOFLAVONE; CYCLOOXYGENASE 2; INDOLO[3,2 B]CARBAZOLE; INTERLEUKIN 1BETA; MESSENGER RNA; MICROSOMAL GLUTATHIONE S TRANSFERASE 1 LIKE 1; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN E2; TERT BUTYLHYDROQUINONE; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ARTICLE; CANCER CELL CULTURE; CANCER PREVENTION; CHEMOPROPHYLAXIS; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA FLANKING REGION; DNA RESPONSIVE ELEMENT; DOWN REGULATION; EXPRESSION VECTOR; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRANSCRIPTION INITIATION; TRANSGENE; UPREGULATION;

EID: 0037667901     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00206-5     Document Type: Article

References (62)

1. Food nutrition and the prevention of cancer: a global perspective. World Cancer Research Fund/American Institute for Cancer Research Expert Panel Report. Washington, DC: American Institute for Cancer Research; 1997. p. 216-51.
2. Verhoeven D.T.H., Verhagen H., Goldbohm R.A., van den Brandt P.A., van Poppel G. A review of mechanisms underlying anticarcinogenicity by brassica vegetables. Chem. Biol. Interact. 103:1997;79-129.
3. Potter J.D. Colorectal cancer: molecules and populations. J. Natl. Cancer Inst. 91:1999;916-932.
4. Marks F., Fürstenberger G. Cancer chemoprevention through interruption of multistage carcinogenesis: the lessons learnt by comparing mouse skin carcinogenesis and human large bowel cancer. Eur. J. Cancer. 36:2000;314-329.
5. Bruce W.R., Giacca A., Medline A. Possible mechanisms relating diet and risk of colon cancer. Cancer Epidemiol. Biomarkers Prev. 9:2000;1271-1279.
6. Smalley W.E., DuBois R.N. Colorectal cancer and nonsteroidal anti-inflammatory drugs. Adv. Pharmacol. 39:1997;1-20.
7. Rao C.V., Tokumo K., Rigotty J., Zang E., Kelloff G., Reddy B.S. Chemoprevention of colon carcinogenesis by dietary administration of Piroxicam, α-difluoromethylornithine, 16α-fluoro-5-androsten-17-one, and ellagic acid individually and in combination. Cancer Res. 51:1991;4528-4534.
8. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 87:1996;803-809.
9. Kawamori T., Rao C.V., Seibert K., Reddy B.S. Chemopreventive activity of celecoxib, a specific cyclo-oxygenase-2 inhibitor against colon carcinogenesis. Cancer Res. 58:1998;409-412.
10. 2 levels in rat colon. Carcinogenesis. 20:1999;425-430.
11. Bennett A., del Tacca M. Prostaglandins in human colonic carcinoma. Gut. 16:1975;409.
12. Rigas B., Goldman I.S., Levine L. Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med. 122:1993;518-523.
13. 2 levels and lymphocyte subsets in portal venous drainage of colorectal cancers. Am. J. Surg. 167:1994;264-267.
14. 2. Gut. 35:1994;675-678.
15. Tsujii M., DuBois R.N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell. 83:1995;493-501.
16. Tsujii M., Kawano S., DuBois R.N. Cyclo-oxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. U.S.A. 94:1997;3336-3340.
17. Tsujii M., Kawano S., Tsujii S., Sawaoka H., Hori M., DuBois R.N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 93:1998;705-716.
18. 2 in human colon cancer cells. Cancer Res. 58:1998;362-366.
19. 2 synthesis in Caco-2 human colon carcinoma cells. Oncogene. 19:2000;5517-5524.
20. 2 increases growth and motility of colorectal carcinoma cells. J. Biol. Chem. 276:2001;18075-18081.
21. Vane J.R., Bakhle Y.S., Botting R.M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38:1998;97-120.
22. Warner T.D., Mitchell J.A. Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum? Proc. Natl. Acad. Sci. U.S.A. 99:2002;13371-13373.
23. 2 biosynthesis. J. Biol. Chem. 275:2000;32775-32782.
24. Jakobsson P.J., Thoren S., Morgenstern R., Samuelsson B. Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc. Natl. Acad. Sci. U.S.A. 96:1999;7220-7225.
25. 2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem. 275:2000;32783-32792.
26. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., DuBois R.N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 107:1994;1183-1188.
27. Kargman S.L., O'Neill G.P., Vickers P.J., Evans J.F., Mancini J.A., Jothy S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res. 55:1995;2556-2559.
28. Sano H., Kawahito Y., Wilder R.L., Hashiramoto A., Mukai S., Asai K., Kimura S., Kato H., Kondo M., Hla T. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human colorectal cancer. Cancer Res. 55:1995;3785-3789.
29. Kutchera W., Jones D.A., Matsunami N., Groden J., McIntyre T.M., Zimmerman G.A., White R.L., Prescott S.M. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc. Natl. Acad. Sci. U.S.A. 93:1996;4816-4820.
30. Fujita T., Matsui M., Takaku K., Uetake H., Ichikawa W., Taketo M.M., Sugihara K. Size-dependent and invasion-dependent increase in cyclooxygenase-2 levels in human colorectal carcinomas. Cancer Res. 58:1998;4823-4826.
31. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Vandeputte L.B.A., Lipsky P.E. Cyclooxygenase in biology and disease. FASEB J. 12:1998;1063-1073.
32. Hao X.P., Bishop A.E., Wallace M., Wang H., Willcocks T.C., Maclouf J., Polak J.M., Knight S., Talbot I.C. Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis. J. Pathol. 187:1999;295-301.
33. 2. J. Biol. Chem. 274:1999;11660-11666.
34. Yoshimatsu K., Golijanin D., Paty P.B., Soslow R.A., Jakobsson P.-J., DeLellis R.A., Subbaramaiah K., Dannenberg A.J. Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer. Clin. Cancer Res. 7:2001;3971-3976.
35. Appleby S.B., Ristimaki A., Neilson K., Narko K., Hla T. Structure of the human cyclo-oxygenase-2 gene. Biochem. J. 302:1994;723-727.
36. Yang X., Hou F., Taylor L., Polgar P. Characterization of human cyclooxygenase-2 gene promoter localization of a TGF-β response element. Biochim. Biophys. Acta. 1350:1997;287-292.
37. Suh N.J., Wang Y.P., Honda T., Gribble G.W., Dmitrovsky E., Hickey W.F., Maue R.A., Place A.E., Porter D.M., Spinella M.J., Williams C.R., Wu G.F., Dannenberg A.J., Flanders K.C., Letterio J.J., Mangelsdorf D.J., Nathan C.F., Nguyen L., Porter W.W., Ren R.F., Roberts A.B., Roche N.S., Subbaramaiah K., Sporn M.B. A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity. Cancer Res. 59:1999;336-341.
38. Shao J.Y., Sheng H.M., Inoue H., Morrow J.D., DuBois R.N. Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells. J. Biol. Chem. 275:2000;33951-33956.
39. Forsberg L., Leeb L., Thoren S., Morgenstern R., Jakobsson P.J. Human glutathione dependent prostaglandin E synthase: gene structure and regulation. FEBS Lett. 471:2000;78-82.
40. Mimura J., Fujii-Kuriyama Y. Regulatory roles of AhR. Environ. Sci. 9:2002;71-81.
41. Ciolino H.P., Daschner P.J., Yeh G.C. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem. J. 340:1999;715-722.
42. MacDonald C.J., Ciolino H.P., Yeh G.C. Dibenzoylmethane modulates aryl hydrocarbon receptor function and expression of cytochromes P450 1A1, 1A2, and 1B1. Cancer Res. 61:2001;3919-3924.
43. Bonnesen C., Eggleston I.M., Hayes J.D. Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer Res. 61:2001;6120-6130.
44. Rushmore T.H., Morton M.R., Pickett C.B. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J. Biol. Chem. 266:1991;11632-11639.
45. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., Oyake T., Hayashi N., Satoh K., Hatayama I., Yamamoto M., Nabeshima Y.-I. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236:1997;313-322.
46. Nguyen T., Sherratt P.J., Pickett C.B. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu. Rev. Pharmacol. Toxicol. 43:2003;233-260.
47. Hayes J.D., McMahon M. Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer Lett. 174:2001;103-113.
48. Chui D.H.K., Tang W., Orkin S.H. cDNA cloning of murine Nrf2 gene, coding for a p45 NF-E2 related transcription factor. Biochem. Biophys. Res. Commun. 209:1995;40-46.
49. Quandt K., Frech K., Karas H., Wingender E., Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:1995;4878-4884.
50. Plummer S.M., Holloway K.A., Manson M.M., Munks R.J.L., Kaptein A., Farrow S., Howells L. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex. Oncogene. 18:1999;6013-6020.
51. Kapahi P., Takahashi T., Natoli G., Adams S.R., Chen Y., Tsien R.Y., Karin M. Inhibition of NF-κB activation by arsenite through reaction with a critical cysteine in the activation loop of IκB kinase. J. Biol. Chem. 275:2000;36062-36066.
52. Rossi A., Kapahi P., Natoli G., Takahashi T., Chen Y., Karin M., Santoro M.G. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase. Nature. 403:2000;103-108.
53. Heiss E., Herhaus C., Klimo K., Bartsch H., Gerhauser C. Nuclear factor κB is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J. Biol. Chem. 276:2001;32008-32015.
54. Korn S.H., Wouters E.F.M., Vos N., Janssen-Heininger Y.M.W. Cytokine-induced activation of nuclear factor-κB is inhibited by hydrogen peroxide through oxidative inactivation of IκB kinase. J. Biol. Chem. 276:2001;35693-35700.
55. Rushmore T.H., Pickett C.B. Transcriptional regulation of the rat glutathione S-transferase Ya subunit gene. Characterization of a xenobiotic-responsive element controlling inducible expression by phenolic antioxidants. J. Biol. Chem. 265:1990;14648-14653.
56. Wölfle D., Marotzki S., Dartsch D., Schäfer W., Marquardt H. Induction of cyclooxygenase expression and enhancement of malignant cell transformation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Carcinogenesis. 21:2000;15-21.
57. Huo P.C., Abe K., Schroeder R.A. Superoxide enhances interleukin 1β-mediated transcription of the hepatocyte-inducible nitric oxide synthase gene. Gastroenterology. 118:2000;608-618.
58. Thompson D., Eling T. Mechanism of inhibition of prostaglandin H synthase by eugenol and other phenolic peroxidase substrates. Mol. Pharmacol. 36:1989;809-817.
59. Schildermam P.A., van Maanen J.M., Smeets E.J., ten Hoor F., Kleinjans J.C. Oxygen radical formation during prostaglandin H synthase-mediated biotransformation of butylated hydroxyanisole. Carcinogenesis. 14:1993;347-353.
60. 2 synthase are markedly affected by glutathione and glutathione peroxidase(s). Biochemistry. 34:1995;3325-3337.
61. Chinery R., Beauchamp R.D., Shyr Y., Kirkland S.C., Coffey R.J., Morrow J.D. Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells. Cancer Res. 58:1998;2323-2327.
62. 2, to glutathione. Biochim. Biophys. Acta. 1584:2002;37-45.